Table 1.
Clinicopathological parameter | High level of CD33 (%) | P value | High level of YAP1 (%) | P value | High level of PTEN (%) | P value |
---|---|---|---|---|---|---|
Age | 0·788 | 0·263 | 0·860 | |||
< 60 years | 43 (64·1) | 23 (33·3) | 34 (51·5) | |||
≥ 60 years | 44 (62·0) | 31 (42·5) | 35 (50·0) | |||
Gender | 0·576 | 0·264 | 0·014 a | |||
Female | 35 (60·3) | 20 (32·8) | 36 (63·2) | |||
Male | 52 (65·0) | 34 (42·0) | 33 (41·8) | |||
Duke stage | 0·027 a | 0·001 a | 0·023 a | |||
A–B | 31 (52·5) | 13 (22·0) | 36 (62·1) | |||
C–D | 56 (70·9) | 41 (49·4) | 33 (42·3) | |||
Histological grade | 0·010 a | 0·001 a | 0·005 a | |||
Well‐moderate | 51 (56·0) | 27 (29·0) | 52 (59·8) | |||
Poor | 34 (79·1) | 25 (58·1) | 15 (34·1) | |||
Metastasis | 0·000 a | 0·000 a | 0·124 | |||
Yes | 57 (87·7) | 38 (55·9) | 29 (43·9) | |||
No | 30 (41·1) | 16 (21·6) | 40 (57·1) |
P < 0·05, as determined by the Pearson χ2 test. High/low PTEN, YAP1, and CD33 values are based on the median density value.